SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- Bridgetech Hong Kong Limited (Bridgetech HK), wholly-owned by Bridgetech Holdings International Inc. , has entered into a long-term strategic alliance agreement with Formosa Biomedical Technology Corporation (FBC) to distribute leading edge medical diagnostic and therapeutic technologies to Taiwan consumers and medical professionals.
FBC is the medical technology subsidiary of Formosa Plastics Group (FPG), a leading Taiwan-based conglomerate with businesses in manufacturing, health care, and medical technologies. FPG also operates a network of hospitals in Taiwan.
Err-Cheng Chan, Executive Vice President of FBC, said, "Formosa Plastics Group has an extensive presence in the Taiwan medical sector and we are excited to have entered into this long-term strategic alliance with Bridgetech. The Group owns around 10,000 hospital beds and accounts for 10% of all patients and 10% of pharmaceuticals consumed in Taiwan."
"We believe that the network of hospitals in Taiwan under Formosa Plastics Group will allow for an effective distribution of our drugs and diagnostic devices which, in turn, will benefit the Taiwanese consumers and medical professionals," commented Michael Chermak, Chairman and CEO of Bridgetech Holdings International Inc. "To strengthen our commitment to this strategic alliance with FBC, we have already established Bridgetech Medicines Limited to handle local operations in Taiwan," added Chermak.
About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in Greater China. The company is bringing emerging drugs, devices and diagnostics to Greater China, with an initial focus on oncology. For additional information, please visit Bridgetech at http://www.bthi.com.
About Formosa Biomedical Technology Corporation
FBC aims at developing and manufacturing high-tech, high quality, safe and healthy products by integrating the three major resources of Formosa Plastics Group in manufacturing, academic studies and clinical research and services. For additional information, please visit FBC at http://www.fbc.com.tw.
Forward-Looking Statements
Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intention or strategies for the future of Bridgetech. Forward-looking statements may be identified by words such as "goals," "plans," "believes," "will," "expects" and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place any undue reliance on any forward-looking statements.
Contacts: Media Relations: Vince Heald, Beck Ellman Heald - 858-453-9600 vheald@behmedia.com Investor Relations: Redwood Consultants, LLC - 415-884-0348
Bridgetech Holdings International, Inc.CONTACT: media, Vince Heald of Beck Ellman Heald, +1-858-453-9600,vheald@behmedia.com; or investors, Redwood Consultants, LLC,+1-415-884-0348, both for Bridgetech Holdings International, Inc.
